SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness
暂无分享,去创建一个
R. Tibshirani | N. Shah | K. Nadeau | J. Zehnder | C. Blish | J. Cochran | T. Jardetzky | S. Boyd | B. Pinsky | P. Kim | O. Wirz | Taia T. Wang | A. Rustagi | A. Rogers | M. Sahoo | T. Pham | C. Hogan | S. Gombar | A. E. Powell | Bryan A. Stevens | Abigail E. Powell | ChunHong Huang | F. Yamamoto | K. Röltgen | J. Najeeb | B. Stevens | Molly Hunter | A. R. Otrelo-Cardoso | Justin Manalac
[1] C. Rice,et al. Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.
[2] J. Peiris,et al. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. , 2020, Cell reports.
[3] A. Aguzzi,et al. Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19 , 2020, bioRxiv.
[4] J. Zehnder,et al. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease , 2020, medRxiv.
[5] Jun Yuan,et al. Antibody responses to SARS-CoV-2 in patients with COVID-19 , 2020, Nature Medicine.
[6] Lei Liu,et al. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[8] Kaijun Jiang,et al. SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup , 2020, Current protocols in microbiology.
[9] Y. Yazdanpanah,et al. Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients , 2020, Emerging infectious diseases.
[10] Y. Wen,et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications , 2020, medRxiv.
[11] B. Pinsky,et al. Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2. , 2020, JAMA.
[12] Y. Wen,et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications , 2020, medRxiv.
[13] Guohong Deng,et al. Viral Kinetics and Antibody Responses in Patients with COVID-19 , 2020, medRxiv.
[14] Tara C Smith,et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19 , 2020, mBio.
[15] Ke Ma,et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.
[16] Shibo Jiang,et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine , 2020, Cellular & Molecular Immunology.
[17] Arturo Casadevall,et al. The convalescent sera option for containing COVID-19. , 2020, The Journal of clinical investigation.
[18] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[19] Lei Liu,et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.
[20] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[21] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[22] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[23] Zhènglì Shí,et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody , 2020, bioRxiv.
[24] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[25] B. Bosch,et al. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections , 2019, Emerging infectious diseases.
[26] Fang Li,et al. Structure, Function, and Evolution of Coronavirus Spike Proteins. , 2016, Annual review of virology.
[27] S. Perlman,et al. Antibody Response and Disease Severity in Healthcare Worker MERS Survivors , 2016, Emerging infectious diseases.
[28] Z. Memish,et al. Transmission of MERS-coronavirus in household contacts. , 2014, The New England journal of medicine.
[29] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .